DXR MEXC RealStocks
Own real DXR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 06:24:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Daxor Corporation (DXR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $8.44, with a market capitalization of $49.51M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.24 to $14.76. This page covers its latest market performance, valuation, price trends and company information.
$49.51M | |
$8.55 | |
$8.95 | |
$8.32 | |
$8.46 | |
16.79K | |
22.12K | |
-- | |
$14.76 | |
$8.24 | |
-- | |
-- |
Daxor Corporation (DXR) last closed at $8.44 as of 2026-11-13 21:05:00, down 1.35% ($0.12) from the previous close of $8.46.
During the latest regular trading session, DXR traded between $8.32 and $8.95, with a volume of 16.79K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Daxor Corporation (DXR) moved from $8.63 to $8.44, representing a decline of 2.26% ($0.20).
The stock traded between $8.24 and $8.95 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 10.96 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 3.0%
DXR is currently trading at $8.44, placing it 3.0% of the way from its 52-week low of $8.24 to its 52-week high of $14.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 750 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Daxor Corporation.
Dividend | |
|---|---|
| Ex-Dividend Date | Jan 5, 2018 |
| Payment Date | Jan 12, 2018 |
| Dividend Per Share | $0.03 |
Eligible investors can buy real shares of Daxor Corporation (DXR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DXR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DXR shares and USD.
DXR Shares to USD
1.00 DXR shares = 8.435 USD
Calculations are estimates based on the latest available price and are for reference only.